Clc1ccc(-c2nn3c(COc4cccc(OCc5nnc6sc(-c7ccc(Cl)cc7)nn56)c4)nnc3s2)cc1
The rule of three is typically followed by orally active drugs, which have a molecular weight of <300, a c LogP of ≤3, a hydrogen bond donor count of ≤3 and a hydrogen bond acceptor count of ≤3. Does the molecule comply with the rule of three?